Please login to the form below

Not currently logged in

Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus

Novo Nordisk headquarters

Drug is first and so far only oral alternative to injectable GLP-1 agonists

New Japanese approvals include first OK for GSK’s anaemia drug Duvroq

GSK - logo on buildingAnd Novartis gets green light for non-small cell lung cancer drug Tabrecta

Novartis pulls EU filing for $3.4bn eye therapy Xiidra

Novartis Basel WebCompany says EMA’s concerns “could not be addressed within the available timeframe”

BMS scores EU okay for first-in-class anaemia drug Reblozyl

Bristol Myers Squibb logoDrug is one of five of Celgene’s late-stage pipeline drugs with blockbuster potential

Novartis agrees $347m settlement for bribery allegations

Novartis HQSettlements involve bribery schemes in Greece and Vietnam

Early knockback for AbbVie as FDA rejects Allergan eye drug

AbbVie buildingDrug as effective as rival Novartis’ drug but has more side effects

CSL licenses uniQure haemophila B gene therapy in $2bn-plus deal

Gene therapy graphic - UniQureCould free patients from the need for regulator injections with clotting factor drugs

FDA approval for Merck’s Keytruda threatens Libtayo in skin cancer

FDA headquarters White OakAnother registration trial of Libtayo is due to report in 2021

EMA starts review of Bavencio in first-line bladder cancer

BavencioResults from phase 3 study may lead to possible approval next year

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

COVID-19 Updates and Daily News

Featured jobs


Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...